These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15993301)
1. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Fong J; Wood F; Fowler B Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301 [TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population. Cuttle L; Naidu S; Mill J; Hoskins W; Das K; Kimble RM Burns; 2007 Sep; 33(6):701-7. PubMed ID: 17644258 [TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds. Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426 [TBL] [Abstract][Full Text] [Related]
4. Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis. Cox SG; Cullingworth L; Rode H S Afr Med J; 2011 Sep; 101(10):728-31. PubMed ID: 22272852 [TBL] [Abstract][Full Text] [Related]
5. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084 [TBL] [Abstract][Full Text] [Related]
6. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns. Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237 [TBL] [Abstract][Full Text] [Related]
7. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study. Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837 [TBL] [Abstract][Full Text] [Related]
8. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. Fraser JF; Cuttle L; Kempf M; Kimble RM ANZ J Surg; 2004 Mar; 74(3):139-42. PubMed ID: 14996161 [TBL] [Abstract][Full Text] [Related]
11. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879 [TBL] [Abstract][Full Text] [Related]
12. Use of Acticoat dressings in burns: what is the evidence? Khundkar R; Malic C; Burge T Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745 [TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful? Varas RP; O'Keeffe T; Namias N; Pizano LR; Quintana OD; Herrero Tellachea M; Rashid Q; Ward CG J Burn Care Rehabil; 2005; 26(4):344-7. PubMed ID: 16006842 [TBL] [Abstract][Full Text] [Related]
15. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707 [TBL] [Abstract][Full Text] [Related]
16. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. Tredget EE; Shankowsky HA; Groeneveld A; Burrell R J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045 [TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection. Inman RJ; Snelling CF; Roberts FJ; Shaw K; Boyle JC Burns Incl Therm Inj; 1984 Oct; 11(1):35-40. PubMed ID: 6391611 [TBL] [Abstract][Full Text] [Related]
18. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106 [TBL] [Abstract][Full Text] [Related]
19. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds]. Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954 [TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department. Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]